Independent Advisor Alliance’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,164
| Closed | -$311K | – | 696 |
|
|
2023
Q1 | $311K | Buy |
+5,164
| New | +$311K | 0.02% | 509 |
|
|
2022
Q4 | – | Sell |
-4,522
| Closed | -$344K | – | 562 |
|
|
2022
Q3 | $344K | Buy |
4,522
+224
| +5% | +$17K | 0.02% | 457 |
|
|
2022
Q2 | $299K | Sell |
4,298
-20
| -0.5% | -$1.39K | 0.02% | 483 |
|
|
2022
Q1 | $358K | Sell |
4,318
-155
| -3% | -$12.9K | 0.02% | 476 |
|
|
2021
Q4 | $336K | Sell |
4,473
-122
| -3% | -$9.16K | 0.02% | 490 |
|
|
2021
Q3 | $534K | Sell |
4,595
-535
| -10% | -$62.2K | 0.03% | 362 |
|
|
2021
Q2 | $1.14M | Buy |
5,130
+52
| +1% | +$11.5K | 0.06% | 253 |
|
|
2021
Q1 | $671K | Sell |
5,078
-48
| -0.9% | -$6.34K | 0.04% | 316 |
|
|
2020
Q4 | $887K | Buy |
5,126
+246
| +5% | +$42.6K | 0.06% | 234 |
|
|
2020
Q3 | $543K | Sell |
4,880
-978
| -17% | -$109K | 0.04% | 274 |
|
|
2020
Q2 | $347K | Buy |
+5,858
| New | +$347K | 0.04% | 341 |
|